Marcantonio Pamela, Del Re Brunella, Franceschini Alessia, Capri Miriam, Lukas Stella, Bersani Ferdinando, Giorgi Gianfranco
Department of Evolutionary Experimental Biology, University of Bologna, Italy.
Bioelectromagnetics. 2010 Sep;31(6):425-33. doi: 10.1002/bem.20581.
The aim of the present study was to assess whether exposure to a sinusoidal extremely low frequency magnetic field (ELF-MF; 50 Hz, 1 mT) can affect proliferation and differentiation in the human neuroblastoma cell line BE(2)C, which is representative of high risk neuroblastomas. Cells were subjected to ELF-MF exposure in the presence or absence of a neuronal differentiating agent (all-trans-retinoic acid, ATRA) for 24-72 h. In each experiment, ELF-MF-exposed samples were compared to sham-exposed samples. Cells exposed to ELF-MF combined with retinoic treatment showed a decreased cellular proliferation and an increased proportion of G(0)/G(1) phase cells compared to cells exposed to either treatment alone. Moreover, ELF-MF- and ATRA-treated cells showed more differentiated morphological traits (a higher neurite number/cell, an increased neurite length), together with a significant increase of mRNA levels of p21(WAF1/CIP1) and cdk5 genes, both involved in neuronal differentiation. In addition, the expression of cyp19 gene, which is involved both in neuronal differentiation and stress response, was evaluated; cyp19 gene expression was enhanced by ATRA treatment and significantly enhanced further by ELF-MF exposure combined with ATRA. In conclusion, our data suggest that ELF-MF exposure can strengthen ATRA effects on neuroblastoma cells.
本研究的目的是评估暴露于正弦极低频磁场(ELF-MF;50Hz,1mT)是否会影响人神经母细胞瘤细胞系BE(2)C的增殖和分化,该细胞系代表高风险神经母细胞瘤。在存在或不存在神经元分化剂(全反式维甲酸,ATRA)的情况下,将细胞暴露于ELF-MF中24至72小时。在每个实验中,将暴露于ELF-MF的样本与假暴露样本进行比较。与单独接受任何一种处理的细胞相比,暴露于ELF-MF联合维甲酸处理的细胞显示出细胞增殖减少,G(0)/G(1)期细胞比例增加。此外,ELF-MF和ATRA处理的细胞表现出更多分化的形态特征(每个细胞的神经突数量增加、神经突长度增加),同时参与神经元分化的p21(WAF1/CIP1)和cdk5基因的mRNA水平显著增加。此外,评估了参与神经元分化和应激反应的cyp19基因的表达;cyp19基因表达通过ATRA处理增强,并通过ELF-MF暴露与ATRA联合进一步显著增强。总之,我们的数据表明,ELF-MF暴露可以增强ATRA对神经母细胞瘤细胞的作用。